Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Arcadia Biosciences (RKDA) Tax Provisions (2016 - 2024)

Arcadia Biosciences' Tax Provisions history spans 11 years, with the latest figure at $8000.0 for Q4 2024.

  • For Q4 2024, Tax Provisions rose 14.29% year-over-year to $8000.0; the TTM value through Dec 2024 reached $15000.0, down 28.57%, while the annual FY2025 figure was $8000.0, 0.0% changed from the prior year.
  • Tax Provisions reached $8000.0 in Q4 2024 per RKDA's latest filing, up from $7000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $17000.0 in Q1 2020 to a low of -$33000.0 in Q4 2020.
  • Average Tax Provisions over 5 years is $1363.6, with a median of $1000.0 recorded in 2021.
  • Peak YoY movement for Tax Provisions: plummeted 900.0% in 2020, then skyrocketed 1200.0% in 2022.
  • A 5-year view of Tax Provisions shows it stood at -$33000.0 in 2020, then soared by 103.03% to $1000.0 in 2021, then surged by 1200.0% to $13000.0 in 2022, then tumbled by 46.15% to $7000.0 in 2023, then grew by 14.29% to $8000.0 in 2024.
  • Per Business Quant, the three most recent readings for RKDA's Tax Provisions are $8000.0 (Q4 2024), $7000.0 (Q4 2023), and $1000.0 (Q2 2023).